J Pathol Transl Med.  2023 Jan;57(1):79-80. 10.4132/jptm.2022.10.14.

What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies

• Cai C

• KMID: 2539040
• DOI: http://doi.org/10.4132/jptm.2022.10.14

Abstract

This compilation of new changes in the diagnosis and treatment of muscle and nerve disease is extracted from the latest publications from the European Neuromuscular Centre International workshops, FDA.gov and clinicaltrials.gov.

Figure

• 

  Fig. 1 Sarcoplasmic MxA expression is considered a sensitive and specific marker for dermatomyositis.

• 

  Fig. 2 Myofibrillar myopathy on Gomori trichrome stain.